Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoh Takekuma

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Quality Improvement for Clinical Practice and Advancing Research by Clinical Pharmacists Using Medical 'Big Data']Kenji Momo, Yoh Takekuma
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 31, 2023
[Quality Improvement for Clinical Practice and Advancing Research by Clinical Pharmacists Using Medical 'Big Data']Yoh Takekuma, Kenji Momo
Biological & Pharmaceutical Bulletin|February 2, 2012
Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomesYoh Takekuma, Keiji Yagisawa, Mitsuru Sugawara
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Clinical Research Using the Large Health Insurance Claims Database]Yoh Takekuma, Shungo Imai, Mitsuru Sugawara
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 4, 2025
Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunctionShunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 2, 2025
Impact of baseline proteinuria on progression-free survival after regorafenib treatment for metastatic colorectal cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Journal of Chemotherapy (Florence, Italy)|March 21, 2025
Evaluation of nausea induced by trifluridine/tipiracil in metastatic colorectal cancer treatmentYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Biochimica Et Biophysica Acta|July 26, 2005
Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolitesMitsuru Sugawara, Takahiro Mochizuki, Yoh Takekuma, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 16, 2020
Hypertriglyceridemia induced by S-1: A novel case report and review of the literatureYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Biological & Pharmaceutical Bulletin|December 2, 2021
Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D SupplementationYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Quality Improvement for Clinical Practice and Advancing Research by Clinical Pharmacists Using Medical 'Big Data']Kenji Momo, Yoh Takekuma
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 31, 2023
[Quality Improvement for Clinical Practice and Advancing Research by Clinical Pharmacists Using Medical 'Big Data']Yoh Takekuma, Kenji Momo
Biological & Pharmaceutical Bulletin|February 2, 2012
Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomesYoh Takekuma, Keiji Yagisawa, Mitsuru Sugawara
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2022
[Clinical Research Using the Large Health Insurance Claims Database]Yoh Takekuma, Shungo Imai, Mitsuru Sugawara
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 4, 2025
Optimization of voriconazole dosage via population pharmacokinetic analysis based on the albumin-bilirubin (ALBI) score of patients with liver dysfunctionShunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 2, 2025
Impact of baseline proteinuria on progression-free survival after regorafenib treatment for metastatic colorectal cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Journal of Chemotherapy (Florence, Italy)|March 21, 2025
Evaluation of nausea induced by trifluridine/tipiracil in metastatic colorectal cancer treatmentYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Biochimica Et Biophysica Acta|July 26, 2005
Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolitesMitsuru Sugawara, Takahiro Mochizuki, Yoh Takekuma, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 16, 2020
Hypertriglyceridemia induced by S-1: A novel case report and review of the literatureYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Biological & Pharmaceutical Bulletin|December 2, 2021
Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D SupplementationYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Pageof 19